CNNFDA advisers vote in favor of approval for RSV vaccines for older adultsMar 1, 2023Janelle C ChavezBy Janelle C Chavezmore_vert
ReutersPfizer gets FDA panel's backing in RSV vaccine raceFeb 28, 2023Mariam E Sunny & Khushi MandowaraBy Mariam E Sunny & Khushi Mandowaramore_vert
CNBCFDA advisors recommend GSK's RSV vaccine for older adults, but flag potential safety risksMar 1, 2023Spencer KimballBy Spencer Kimballmore_vert
Daily MailPfizer's new RSV vaccine for older adults may trigger potentially deadly Guillain-Barre syndromeFeb 27, 2023Luke AndrewsBy Luke Andrewsmore_vert
The New York TimesF.D.A. Panel Recommends 2 R.S.V. Vaccines for Older Adults (Published 2023)Mar 1, 2023Christina JewettBy Christina Jewettmore_vert